IK PARTNERS takes majority stake in Acture Group

The Pan-European private equity firm IK Investment Partners signs a definitive agreement to acquire a majority stake in Acture Groep, formally transitioning control from the target's founding shareholders. Executed through the specialized IK Small Cap II fund (a €550 million investment vehicle that successfully closed in the first quarter of 2018) this LBO represents the ninth distinct corporate investment finalized by this specific capital pool. At the time of this ownership transition, the targeted social security provider demonstrated robust profitability metrics, having been actively marketed to potential buyers based on an annual adjusted EBITDA of . Under the rigorously negotiated capital restructuring, the foundational executive team retains a significant operational role; notably, the current Chief Executive Officer will explicitly remain in her leadership capacity and substantially reinvest her personal proceeds alongside the incoming institutional sponsor. This co-investment mechanism ensures strict alignment of strategic interests and guarantees operational continuity during the post-acquisition integration phase. The strategic rationale articulated by the acquiring board focuses on deploying fresh programmatic capital to support the target's accelerated growth trajectory, specifically aiming to expand its proprietary service portfolio and push its international offering across adjacent European jurisdictions. The incoming financial sponsor intends to leverage its extensive historical expertise in the healthcare and tech-enabled services sectors to optimize the target's compliance workflows and scale its overarching business model. Throughout the competitive transaction process, the sell-side execution and financial auction mechanics were exclusively advised by the investment banking firm Lincoln International. By orchestrating this cross-border capital injection, the acquiring entity secures a highly profitable, dominant regional platform equipped to navigate the increasing complexities of European social security legislation, effectively establishing a robust foundation for future strategic add-on acquisitions across international markets.